Table 5 Summary of markers significantly associated with growth-related QTL in LG53.
Trait | Marker | Position (cM) | LOD | Explained phenotype (%) | Scaffold ID | Annotation |
|---|---|---|---|---|---|---|
Body length | Marker253119 | 169.43 | 59.09 | 95.5 | Scaffold225377 | LNX2; FMRFamide and octopamine receptor |
Marker01950 | 170.01 | 59.39 | 95.5 | / | / | |
Marker209500 | 170.60 | 59.77 | 95.5 | Scaffold291249 | PAK2 | |
Body width | Marker253119 | 169.43 | 50.51 | 93.8 | Scaffold225377 | LNX2; FMRFamide and octopamine receptor |
Marker01950 | 170.01 | 50.87 | 93.8 | / | / | |
Marker209500 | 170.60 | 51.21 | 93.8 | Scaffold291249 | PAK2 | |
Body weight | Marker253119 | 169.43 | 16.73 | 78.6 | Scaffold225377 | LNX2; FMRFamide and octopamine receptor |
Marker01950 | 170.01 | 17.07 | 78.5 | / | / | |
Marker209500 | 170.60 | 17.48 | 78.5 | Scaffold291249 | PAK2 |
